BECN1 and malignant colon neoplasm: Experiments using multidrug treatment of colon cancer cells indicated that AMPK activation promoted apoptosis by phosphorylating Beclin-1 at Ser93/96, which increases Beclin-1 cleavage by caspase-8 [50].